Healthequity (HQY) PT Raised to $61.00 at Robert W. Baird
Healthequity (NASDAQ:HQY) had its price objective hoisted by analysts at Robert W. Baird from $49.00 to $61.00 in a report issued on Tuesday. The firm presently has a “neutral” rating on the stock. Robert W. Baird’s target price would indicate a potential downside of 6.81% from the company’s current price. The analysts noted that the move was a valuation call.
A number of other research firms also recently issued reports on HQY. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Friday, December 22nd. Citigroup began coverage on shares of Healthequity in a research report on Thursday, January 4th. They set a “buy” rating on the stock. Chardan Capital upped their target price on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Cantor Fitzgerald restated a “buy” rating and set a $56.00 target price on shares of Healthequity in a research report on Tuesday, December 5th. Finally, JPMorgan Chase & Co. cut their target price on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 24th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $64.80.
Shares of Healthequity (NASDAQ:HQY) opened at $65.46 on Tuesday. Healthequity has a fifty-two week low of $37.62 and a fifty-two week high of $66.25. The company has a market cap of $3,925.65, a PE ratio of 93.54, a price-to-earnings-growth ratio of 2.90 and a beta of 1.46.
Large investors have recently made changes to their positions in the stock. Global X Management Co. LLC raised its position in shares of Healthequity by 180.6% in the 4th quarter. Global X Management Co. LLC now owns 36,601 shares of the company’s stock valued at $1,708,000 after acquiring an additional 23,556 shares during the period. Amussen Hunsaker Associates LLC raised its position in shares of Healthequity by 1.9% in the 3rd quarter. Amussen Hunsaker Associates LLC now owns 237,239 shares of the company’s stock valued at $12,000,000 after acquiring an additional 4,493 shares during the period. Signition LP acquired a new stake in shares of Healthequity in the 4th quarter valued at approximately $348,000. Dixon Hubard Feinour & Brown Inc. VA acquired a new stake in shares of Healthequity in the 3rd quarter valued at approximately $5,071,000. Finally, Dimensional Fund Advisors LP raised its position in shares of Healthequity by 12.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 531,288 shares of the company’s stock valued at $26,872,000 after acquiring an additional 57,855 shares during the period. Institutional investors and hedge funds own 99.62% of the company’s stock.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.